Matthew Malone, DO, MBA

  • 2Articles
  • 7.9KReads
  • 2022Active
  • 1Collaborators
  • 4Citations

About

Matthew Malone, DO, MBA, is affiliated with the Banner Alzheimer’s Institute in Tucson, Arizona. His publications focus on dementia and neurology, specifically addressing the screening, differential diagnosis, and treatment of mild cognitive impairment and Alzheimer disease. He has contributed articles to Psychiatrist.com, collaborating frequently with co-author Allan Anderson.

Publications

JCP
Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease
Commentary

Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease

December 26, 2022

Among the most transformative Alzheimer disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.
,
JCP
The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease
Commentary

The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease

December 26, 2022

Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe